| 英文别名 |
nimesulide;nimed;4-NITRO-2-PHENOXYMETHANE SULPHONANILIDE;MESULID;AULIN;FANSIDOL;CETIRIZINE DIHYDROCHLORIDE EPC(CRM STANDARD);CETIRIZINE DIHYDROCHLORIDE IMP. E (EP):(RS)-2-[2-[2-[4-[(4-CHLOROPHENYL)-PHENYLMETHYL]PIPERAZIN-1-YL]ETHOXY]ETHOXY]ACETIC ACID MM(CRM STANDARD);CETIRIZINE DIHYDROCHLORIDE MM(CRM STANDARD);N-(4-nitro-2-phenoxyphenyl)methanesulfonamide;R805;4-nitro-2-phenoxymethanesulfonanilide;Antifloxil;Flogovital;Guaxan;N-(2-phenoxy-4-nitrophenyl)methanesulfonamide;N-(4-Nitro-2-phenoxy-phenyl)-methanesulfonamide;N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide Nimesulide;R-805;Sulidene;N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide;N-(4-Nitro-2-Phenoxy)Methanesulfonanilide;Nisulid;Nimesulidum [INN-Latin];Nimesulida [INN-Spanish];R 805;4-Nitro-2-phenoxy-methanesulfonanilide;4'-Nitro-2'-phenoxymethanesulfonanilide;Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-;4'-Nitro-2'-phenoxymethansulfonanilid;MLS000069680;V4TKW1454M;Methanesulfonanilide, 4'-nitro-2'-phenoxy-;C;N-[4-nitro-2-(phenoxy)phenyl]methanesulfonamide;Prestwick_618;NCGC00015725-29;W-105866;CHEMBL56367;NCGC00015725-12;1364966-82-4;MLS001148268;HMS2095H09;UNII-V4TKW1454M;BSPBio_000147;Spectrum_001577;SPBio_001382;HMS2234K19;Nimesulidum;Prestwick1_000194;A828786;NCGC00015725-03;Nimesulide for peak identification;NCGC00015725-13;D70376;CCRIS 8225;SW196785-3;CHEBI:44445;NIMESULIDE [INN];Pharmakon1600-01503231;BCBcMAP01_000034;HMS502C15;SR-01000000218-11;KBio1_000693;LP00855;SPECTRUM1503231;51803-78-2;Spectrum3_001576;SDCCGSBI-0050831.P004;NIM-03;NIMESULIDE [MI];NCGC00015725-09;SR-01000000218-6;KS-1277;N0984;NIMESULIDE (EP MONOGRAPH);Lopac-N-1016;KBioGR_000443;SR-01000000218-2;Tox21_301850;AKOS015897356;NSC-758412;HMS3678P07;Nimedex;Tox21_110207;NCGC00015725-01;HMS3371J19;EU-0100855;BSPBio_003112;NCGC00255661-01;Nise Gel;KBioSS_000443;Tox21_500855;DTXSID3037250;NSC 758412;NCGC00015725-06;SMR000058484;HMS1922K17;BRN 2421175;KBio2_002057;KBio2_000443;Bio2_000862;HMS1990G05;NIMESULIDE [MART.];HMS3655D13;Nimesulide, European Pharmacopoeia (EP) Reference Standard;FT-0630650;AB00052332-16;Aldoron;NCGC00021842-06;KBio2_004625;NIM;Orthobid;HMS1792G05;Nimesulide [INN:BAN];BN166246;M01AX17;NINDS_000693;NIMESULIDE [JAN];HMS3262L11;NCGC00015725-16;AB00052332_18;Q20994;Nimesulide (JAN/INN);NCGC00021842-04;AC-4524;NCGC00021842-03;Lopac0_000855;BCP10076;NCGC00015725-02;NCGC00015725-04;BDBM50056999;NCGC00261540-01;EN300-7388636;BSPBio_001103;Nimesulide, Pharmaceutical Secondary Standard; Certified Reference Material;Prestwick3_000194;Prestwick0_000194;N-(4-nitro-2-phenoxyphenyl);CAS-51803-78-2;AB00052332_17;NIMESULIDE [EP IMPURITY];GTPL7401;DB04743;Opera_ID_1247;Nimesulide,(S);D01049;Nimesulide for peak identification, European Pharmacopoeia (EP) Reference Standard;KBio3_002612;HMS1362G05;NCGC00021842-05;Spectrum2_001541;KBio2_007193;HY-B0363;NIMESULIDE (EP IMPURITY);NS00006725;N-(4-ni... |